Ionis Pharmaceuticals Inc (NASDAQ: IONS) has reported E.P.S. of $-0.66 for its fourth fiscal quarter (ending December 31) versus $-0.06 for the same period a year ago — an increase of 1000%. E.P.S. were $-3.04 […]
Barfresh Food Group Inc (NASDAQ: BRFH) stock enjoyed a major increase of 18.1% on 2/19/25. The shares closed at $4.54. Moreover, trading volume in this advance was exceptionally high at 526% of normal. Relative to […]
For its fourth fiscal quarter (ending December 31), Amicus Therapeutics Inc (NASDAQ: FOLD) has reported a -145% decline in E.P.S. from $-0.11 a year ago to $0.05 in the current quarter. For the latest four […]
Watsco Inc (NYSE: WSO) has reported earnings for its fourth fiscal quarter (ending December 31) of $2.37 versus $2.08 for the same period a year ago — an increase of 14%. E.P.S. were $13.30 for […]
For its fourth fiscal quarter (ending December 31), CVR Energy Inc (NYSE: CVI) has reported a -69% decline in E.P.S. from $0.91 a year ago to $0.28 in the current quarter. E.P.S. were $0.06 for […]
Brookdale Senior Living Inc (NYSE: BKD) has reported E.P.S. of $-0.37 for its fourth fiscal quarter (ending December 31) versus $-0.40 for the same period a year ago — a decline of -8%. For the […]
Sapiens International Corp NV (NASDAQ: SPNS) has reported E.P.S. of $0.32 for its fourth fiscal quarter (ending December 31) versus $0.30 for the same period a year ago — an increase of 7%. For the […]
Expeditors International of Wash (NYSE: EXPD) has reported E.P.S. of $1.69 for its fourth fiscal quarter (ending December 31) versus $1.09 for the same period a year ago — an increase of 55%. For the […]
Ardelyx Inc (NASDAQ: ARDX) stock closed at $6.42 on 2/18/25 after a major increase of 10.9%. NORMAL trading volume accompanied the advance. The stock has risen 15.1% during the last week but has been weak […]
For its fourth fiscal quarter (ending December 31), Genuine Parts Co (NYSE: GPC) has reported a -58% decline in E.P.S. from $2.27 a year ago to $0.96 in the current quarter. For the latest four […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research